Main menu

NCM 2023 Houston: Building and applying global pathogen surveillance in a post/peri-pandemic world


APHL Global Health leverages next-generation sequencing (NGS), bioinformatics, and genomic epidemiology to enhance public health decision-making in 78 countries. NGS emerged as a crucial component of the COVID-19 pandemic response, with internal and external investments catalyzing advancements in global pathogen genomic capabilities. We emphasize establishing regional capacities in a post/peri-pandemic setting, enabling real-time technical support. A fundamental principle is prioritizing a south-to-south global approach, fostering collaboration among nations with similar challenges. Crucially, we aim to assess the costs of pathogen genomics initiatives, ensuring their long-term sustainability. Exploring diverse use cases demonstrates the broad impact of pathogen genomics on public health outcomes, attracting funding from various entities. While the COVID-19 pandemic brought enduring challenges, it accelerated global pathogen genomics by a decade. APHL seeks to harness this momentum by showcasing the transformative potential of NGS technology, bioinformatics, genomic epidemiology, and data visualization, fostering better health outcomes at individual and population levels

Authors: Noah C. Hull

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag